Which hedge funds own SVA? SINOVAC BIOTECH LTD, Q2 2026 13F holders
2 of the hedge funds tracked by WhaleCreep disclosed a position in SVA (SINOVAC BIOTECH LTD) in their Q2 2026 13F filings, worth $186.5m in total. The largest holder by portfolio weight is Orbimed Advisors LLC at 3.5% of its book.
2tracked managers holding
0opened this quarter
0exited this quarter
Which hedge funds hold SVA? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Orbimed Advisors LLC | Q2 2026 | 3.5% | $184.5m | 2,718,735 | 0% | held |
| Neumann Advisory Hong Kong LTD | Q2 2026 | 0.6% | $2.0m | 315,586 | 0% | held |
How has hedge fund ownership of SVA changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 4 | $186.5m |
| Q1 2026 | 4 | $186.5m |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $849.2k |
| Q2 2024 | 1 | $849.2k |
| Q1 2024 | 1 | $849.0k |
| Q3 2023 | 1 | $1.5m |
| Q2 2023 | 1 | $1.5m |
| Q3 2022 | 1 | $1.5m |
| Q2 2022 | 1 | $1.5m |
| Q4 2021 | 1 | $1.5m |
| Q3 2021 | 1 | $1.5m |
| Q2 2021 | 1 | $1.5m |
| Q1 2021 | 1 | $1.5m |
| Q4 2020 | 1 | $1.5m |
Counts every tracked manager that disclosed SVA in that quarter's filing, including managers that have since stopped filing.